Klas Kullander Selected Research

Vesicular Glutamate Transport Protein 2

10/2014	Multimodal use of calcitonin gene-related peptide and substance P in itch and acute pain uncovered by the elimination of vesicular glutamate transporter 2 from transient receptor potential cation channel subfamily V member 1 neurons.
2/2014	Glutamate, substance P, and calcitonin gene-related peptide cooperate in inflammation-induced heat hyperalgesia.
4/2011	A sensory subpopulation depends on vesicular glutamate transporter 2 for mechanical pain, and together with substance P, inflammatory pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klas Kullander Research Topics

Disease

5	Pain (Aches) 10/2014 - 11/2010
4	Hyperalgesia 02/2014 - 11/2010
3	Neuralgia (Stump Neuralgia) 07/2012 - 11/2010
2	Gliosis 01/2017 - 11/2012
2	Hydronephrosis 01/2016 - 07/2013
2	Hypersensitivity (Allergy) 03/2015 - 01/2015
2	Acute Pain 10/2014 - 11/2010
2	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2010 - 08/2008
1	Tinnitus 01/2021
1	Motor Disorders 01/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Anaphylaxis (Anaphylactic Shock) 01/2016
1	Immune System Diseases (Immune Disorders) 01/2016
1	Huntington Disease (Huntington's Disease) 01/2015
1	Inflammation (Inflammations) 02/2014
1	Hypertension (High Blood Pressure) 07/2013
1	Disease Progression 05/2013
1	Chronic Pain 07/2012
1	Colorectal Neoplasms (Colorectal Cancer) 06/2012
1	Substance-Related Disorders (Drug Abuse) 08/2011
1	Feeding and Eating Disorders (Eating Disorder) 08/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2010

Drug/Important Bio-Agent (IBA)

5	Glutamic Acid (Glutamate)FDA Link 01/2015 - 01/2010
3	Substance PIBA 10/2014 - 04/2011
3	Vesicular Glutamate Transport Protein 2IBA 10/2014 - 04/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2015 - 02/2014
2	Calcitonin Gene-Related PeptideIBA 10/2014 - 02/2014
2	Transient Receptor Potential ChannelsIBA 10/2014 - 02/2014
2	Vesicular Glutamate Transport ProteinsIBA 07/2012 - 11/2010
2	Formaldehyde (Formol)FDA Link 04/2011 - 11/2010
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2016
1	CalciumIBA 01/2016
1	metabotropic glutamate receptor 7IBA 01/2016
1	EphrinsIBA 01/2016
1	Tranylcypromine (Parnate)FDA LinkGeneric 03/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 03/2015
1	gamma-Aminobutyric Acid (GABA)IBA 01/2015
1	EphA4 ReceptorIBA 07/2013
1	SaltsIBA 07/2013
1	enhanced green fluorescent proteinIBA 07/2013
1	Cholinergic Agents (Cholinergics)IBA 05/2013
1	ProcalcitoninIBA 05/2013
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2013
1	CalbindinsIBA 05/2013
1	Coloring Agents (Dyes)IBA 11/2012
1	Netrin-1IBA 06/2012
1	DCC ReceptorIBA 06/2012
1	Dopamine (Intropin)FDA LinkGeneric 08/2011
1	Nerve Growth Factor (NGF)IBA 04/2011
1	Ephrin-B2 (Ephrin B2)IBA 11/2010
1	N-Methylaspartate (NMDA)IBA 11/2010
1	Eph Family Receptors (Eph Receptors)IBA 11/2010
1	Freund's AdjuvantIBA 11/2010
1	Tyrosine (L-Tyrosine)FDA Link 11/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2010
1	TRPV Cation ChannelsIBA 11/2010
1	Chemokine CXCL10IBA 03/2010
1	ChemokinesIBA 08/2008

Therapy/Procedure

2	Therapeutics 01/2019 - 07/2012
1	Ligation 07/2012